Cystatin C as a biomarker of chronic kidney disease: latest developments
Introduction Chronic kidney disease (CKD) is common, occurring in over 10% of individuals globally, and is increasing in prevalence. The limitations of traditional biomarkers of renal dysfunction, such as serum creatinine, have been well demonstrated in the literature. Therefore, augmenting clinical...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Revisão |
| Sprache: | Englisch |
| Veröffentlicht: |
2020
|
| Online-Zugang: | https://doi.org/10.1080/14737159.2020.1768849 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!